Skip to content

Vanderbilt-Zambia Innovations in Global Health Technologies

Vanderbilt-Zambia Innovations in Global Health Technologies

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02700269
Acronym
VZNIGHT
Enrollment
278
Registered
2016-03-07
Start date
2016-04-30
Completion date
2019-02-28
Last updated
2020-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria Diagnosis

Brief summary

Investigators will evaluate approaches using magnetic bead capture, isolation, and surface tension valve transfer of biomarkers to process capillary blood in order to improve the sensitivity of already approved Rapid Diagnostic Tests (RDTs) for detection of human malaria infection. Results will be compared to those obtained using unenhanced capillary blood specimens directly applied to approved malaria RDTs. Participants seeking care for possible malaria in Zambia will be recruited to enroll in the study.

Interventions

OTHERmBEADS

Evaluate approaches using magnetic bead capture, isolation, and surface tension valve transfer of biomarkers to improve the sensitivity of already approved malaria RDTs.

Sponsors

Vanderbilt University
CollaboratorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
Fogarty International Center of the National Institute of Health
CollaboratorNIH
Macha Research Trust, Zambia
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Months to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Individuals giving written informed consent for themselves * Children under the age of 18 for whom a parent or guardian can give consent * Individuals seeking care or treatment of suspected or possible malaria * Individuals being screened as a contact of someone with recent malaria * Other individuals willing to have their blood tested for malaria

Exclusion criteria

* Anyone over 18 unwilling or unable to provide informed consent * Anyone under 18 who does not have a parent or guardian to give consent * Anyone between the age of 12 and 18 who does not give assent

Design outcomes

Primary

MeasureTime frameDescription
Enhancement of malaria RDT to detect low levels of P falciparum parasites5 yearsThe expected outcome of this research project is to enhance the ability of standard malaria RDTs to detect low levels of Plasmodium falciparum malaria in human capillary blood.

Countries

Zambia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026